This report contains market size and forecasts of Network Point-of-Care Glucose Testing Device in global, including the following market information:
Global Network Point-of-Care Glucose Testing Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Network Point-of-Care Glucose Testing Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Network Point-of-Care Glucose Testing Device companies in 2021 (%)
The global Network Point-of-Care Glucose Testing Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.5uL/0.6uL Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Network Point-of-Care Glucose Testing Device include Roche Holding AG, Ascensia Diabetes Care Holdings AG, Nova Biomedical, LifeScan, Inc., Danaher Corporation, Prodigy Diabetes Care, Johnson & Johnson, Nipro and ACON Laboratories, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Network Point-of-Care Glucose Testing Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Network Point-of-Care Glucose Testing Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Network Point-of-Care Glucose Testing Device Market Segment Percentages, by Type, 2021 (%)
0.5uL/0.6uL
1uL
1.5uL
Others
Global Network Point-of-Care Glucose Testing Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Network Point-of-Care Glucose Testing Device Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Household
Global Network Point-of-Care Glucose Testing Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Network Point-of-Care Glucose Testing Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Network Point-of-Care Glucose Testing Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Network Point-of-Care Glucose Testing Device revenues share in global market, 2021 (%)
Key companies Network Point-of-Care Glucose Testing Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Network Point-of-Care Glucose Testing Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Holding AG
Ascensia Diabetes Care Holdings AG
Nova Biomedical
LifeScan, Inc.
Danaher Corporation
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo